Generic Name and Formulations:
Ferumoxsil 175mcg/mL; susp; contains parabens 1.4mg/mL.
Indications for GASTROMARK:
For oral use with magnetic resonance imaging to enhance the delineation of the bowel to distinguish it from organs and tissues that are adjacent to the upper regions of the GI tract.
Take after fasting at least 4 hours. 600mL orally at a rate of 300mL over 15 minutes. Max dose: 900mL. Optimal results occur within 30 minutes.
<16yrs: not recommended.
Known or suspected intestinal perforation or obstruction.
Current or recent hiatal hernia, esophageal reflux, nausea, vomiting, abdominal pain. Patients who cannot tolerate large fluid shifts and who are on specific fluid requirements. Inflammatory bowel disease. Disorders associated with iron overload (eg, hemosiderosis, chronic hemolytic anemia with frequent blood transfusions, chronic iron replacement). Avoid aspiration. Pregnancy (Cat.B). Nursing mothers.
Superparamagnetic iron oxide.
Diarrhea, flatulence, nausea, abdominal pain/cramps, dyspepsia, vomiting, oral paresthesia.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age